WCN March 1 - 2026 Supporting materials POSTER: Effect of Sibeprenlimab on Hematuria in Adults With IgA Nephropathy: Interim Analysis of the VISIONARY Phase 3 Trial POSTER: Interval from Urinary Abnormalities in Health Checkups to the Diagnosis of IgA Nephropathy: A Descriptive Study Using Health Insurance Claims Data in Japan POSTER: VISOR: An Ongoing Clinical Trial Assessing Changes in Kidney Histology Through Repeat Kidney Biopsies in Adults With IgA Nephropathy Treated With Sibeprenlimab POSTER: Eight years of Canadian Real-World Assessment of Tolvaptan in ADPKD: Patient Reported Outcomes from the C-MAJOR study POSTER: Evaluating Sibeprenlimab in Patients With IgA Nephropathy: Results From an Interim Analysis of the China Cohort of the Phase 3 VISIONARY Trial ABSTRACT: Effect of Sibeprenlimab on Hematuria in Adults With IgA Nephropathy: Interim Analysis of the VISIONARY Phase 3 Trial
